14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

OTIC Predictions History

6 years ago
bbullish2 predicted that OTIC for 2018-02-26 is going $5.81 (-1.53%)

Click to get the best stock tips daily for free!

About Otonomy

Otonomy Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the trea... OTIC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT